ZA80553B - Process for the preparation of tablets with retarded liberation of the active agent,in which tablets the rate of liberation of the active agent is predetermined - Google Patents

Process for the preparation of tablets with retarded liberation of the active agent,in which tablets the rate of liberation of the active agent is predetermined

Info

Publication number
ZA80553B
ZA80553B ZA00800553A ZA80553A ZA80553B ZA 80553 B ZA80553 B ZA 80553B ZA 00800553 A ZA00800553 A ZA 00800553A ZA 80553 A ZA80553 A ZA 80553A ZA 80553 B ZA80553 B ZA 80553B
Authority
ZA
South Africa
Prior art keywords
tablets
active agent
liberation
preparation
rate
Prior art date
Application number
ZA00800553A
Other languages
English (en)
Inventor
G Sothmann
E Marttila
Original Assignee
Orion Yhtymae Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oy filed Critical Orion Yhtymae Oy
Publication of ZA80553B publication Critical patent/ZA80553B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
ZA00800553A 1979-02-02 1980-01-30 Process for the preparation of tablets with retarded liberation of the active agent,in which tablets the rate of liberation of the active agent is predetermined ZA80553B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI790350A FI63335B (fi) 1979-02-02 1979-02-02 Foerfarande foer framstaellning av tabletter med foerdroejd loslighet av effektaemne

Publications (1)

Publication Number Publication Date
ZA80553B true ZA80553B (en) 1981-02-25

Family

ID=8512353

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00800553A ZA80553B (en) 1979-02-02 1980-01-30 Process for the preparation of tablets with retarded liberation of the active agent,in which tablets the rate of liberation of the active agent is predetermined

Country Status (15)

Country Link
US (1) US4351825A (fr)
EP (1) EP0014514B1 (fr)
JP (1) JPS55129222A (fr)
AR (1) AR222207A1 (fr)
AT (1) ATE20182T1 (fr)
CA (1) CA1144071A (fr)
DE (1) DE3071625D1 (fr)
DK (1) DK28480A (fr)
ES (1) ES488168A0 (fr)
FI (1) FI63335B (fr)
GR (1) GR65623B (fr)
IE (1) IE51741B1 (fr)
NO (1) NO149490B (fr)
PT (1) PT70719A (fr)
ZA (1) ZA80553B (fr)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1168014B (it) * 1981-08-05 1987-05-20 Erba Farmitalia Forme farmaceutiche a cessione protratta
DE3314003A1 (de) * 1983-04-18 1984-10-18 Boehringer Ingelheim KG, 6507 Ingelheim Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
HU190619B (en) * 1983-11-11 1986-09-29 Bezzegh,Denes,Hu Process for producing tablets with controlled dissolution of active ingredients
FR2556965B1 (fr) * 1983-12-21 1986-08-22 Rhone Poulenc Sante Nouvelle forme galenique du ketoprofene a liberation controlee
US4927633A (en) * 1984-03-19 1990-05-22 Alza Corporation Dispenser for delivering drug to livestock
US4624945A (en) * 1984-03-19 1986-11-25 Alza Corporation Dispensing system with means for increasing delivery of beneficial agent from the system
US4729793A (en) * 1985-08-09 1988-03-08 Alza Corporation Composition for manufacturing wall of dispensing device
US4844984A (en) * 1984-03-19 1989-07-04 Alza Corporation Dispensing system with means for increasing delivery of beneficial agent from the system
US5000957A (en) * 1984-03-19 1991-03-19 Alza Corporation Dispenser comprising hydrophilic osmopolymer
US4684524A (en) * 1984-03-19 1987-08-04 Alza Corporation Rate controlled dispenser for administering beneficial agent
US4629621A (en) * 1984-07-23 1986-12-16 Zetachron, Inc. Erodible matrix for sustained release bioactive composition
FR2573307B1 (fr) * 1984-11-22 1988-06-10 Virbac Ctre Rech Biolog Implants anabolisants a liberation prolongee
DE3524003A1 (de) * 1985-07-04 1987-01-08 Heumann Ludwig & Co Gmbh Arzneimittelgranulat mit verzoegerter wirkstofffreisetzung und verfahren zu seiner herstellung
GB2186485B (en) * 1986-02-13 1988-09-07 Ethical Pharma Ltd Slow release formulation
IT1204294B (it) * 1986-03-11 1989-03-01 Gentili Ist Spa Metodo di fabbricazione di granulari atti a produzione di compresse rivestite,per uso orale,a rilascio controllato
US5624683A (en) * 1986-08-06 1997-04-29 Eisai Co., Ltd. Sustained-release multi-granule tablet
EP0406315B1 (fr) * 1988-03-24 1992-11-11 Bukh Meditec A/S Composition a diffusion regulee
US6056992A (en) * 1988-06-02 2000-05-02 Campbell Soup Company Encapsulated additives
US5268182A (en) * 1988-06-24 1993-12-07 Abbott Laboratories Sustained-release drug dosage units of terazosin
US5169642A (en) * 1988-06-24 1992-12-08 Abbott Laboratories Sustained-release drug dosage units
PH26730A (en) * 1988-12-30 1992-09-28 Ciba Geigy Ag Coated adhesive tablets
US4970081A (en) * 1989-01-03 1990-11-13 Sterling Drug Inc. Controlled-release, low-dose aspirin formulation and method of treating vascular occlusive disease therewith
IL96311A (en) † 1989-12-01 1995-05-26 Abbott Lab Medications with delayed release
GB9015822D0 (en) * 1990-07-18 1990-09-05 Beecham Group Plc Compositions
US5266331A (en) * 1991-11-27 1993-11-30 Euroceltique, S.A. Controlled release oxycodone compositions
US20080075781A1 (en) * 1992-11-25 2008-03-27 Purdue Pharma Lp Controlled release oxycodone compositions
US20070275062A1 (en) * 1993-06-18 2007-11-29 Benjamin Oshlack Controlled release oxycodone compositions
US5431630A (en) * 1993-09-07 1995-07-11 Surgic-Acid, Inc. Needle guard and nonreusable syringe
US6103262A (en) * 1994-01-27 2000-08-15 G. D. Searle & Company Modified-release metronidazole compositions and methods for making and using same
US5484608A (en) * 1994-03-28 1996-01-16 Pharmavene, Inc. Sustained-release drug delivery system
GB9522403D0 (en) * 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
US6776996B2 (en) 1997-07-09 2004-08-17 Basf Aktiengesellschaft Pesticidal matrices
ID20839A (id) * 1997-07-09 1999-03-11 American Cyanamid Co Bahan acuan pestisida berlapis lebih baik, pengolahan pada pembuatannya serta komposisi-komposisi yang terkandung di dalamnya
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
CN1203846C (zh) 1998-03-19 2005-06-01 布里斯托尔-迈尔斯斯奎布公司 高溶解性药物的双相控释递送系统和方法
US6099859A (en) 1998-03-20 2000-08-08 Andrx Pharmaceuticals, Inc. Controlled release oral tablet having a unitary core
EP1949890A3 (fr) 1999-06-04 2011-05-18 ALZA Corporation Compositions de gel implantables et procédé de fabrication
HUP0201626A3 (en) * 1999-06-04 2004-05-28 Alza Corp Mountain View Implantable gel compositions and method of manufacture
US6676966B1 (en) 2000-05-09 2004-01-13 Intellipharmaceutics Corp. Extended release metformin hydrochloride formulations
GB0102342D0 (en) * 2001-01-30 2001-03-14 Smithkline Beecham Plc Pharmaceutical formulation
US20050175687A1 (en) * 2001-01-30 2005-08-11 Mcallister Stephen M. Pharmaceutical formulations
US7883721B2 (en) 2001-01-30 2011-02-08 Smithkline Beecham Limited Pharmaceutical formulation
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
DE10127134A1 (de) * 2001-06-05 2002-12-12 Roehm Gmbh verfahren zur Herstellung von Formkörpern aus (Meth)acrylat-Copolymeren mittels Spritzguß
WO2003105809A1 (fr) 2002-06-17 2003-12-24 Themis Laboratories Private Limited Comprimes multicouche contenant des thiazolidinediones et des biguanides et procedes de production desdits comprimes
EP1549296A4 (fr) * 2002-08-02 2006-08-09 Penwest Pharmaceuticals Co Preparations a liberation soutenue de metformine
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
US7135436B2 (en) * 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
PE20060003A1 (es) 2004-03-12 2006-03-01 Smithkline Beecham Plc Formulacion farmaceutica polimerica para moldear por inyeccion

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
US3062720A (en) * 1959-05-20 1962-11-06 Philips Roxane Sustained release pharmaceutical tablet
US3148124A (en) * 1962-06-12 1964-09-08 William E Gaunt Method of preparing sustained release pharmaceutical tablets
CH415963A (de) * 1964-09-04 1966-06-30 Wander Ag Dr A Masse zur Herstellung von Tabletten mit protrahierter Wirkung
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
SE353229B (fr) * 1970-06-04 1973-01-29 Haessle Ab
GB1500300A (en) * 1975-01-06 1978-02-08 Ciba Geigy Ag Pharmaceutical preparation for the treatment of circulatory disorders
JPS6191314A (ja) * 1984-10-12 1986-05-09 Nippon Kokan Kk <Nkk> 取鍋精錬炉による溶鋼の精錬方法

Also Published As

Publication number Publication date
NO794290L (no) 1980-08-05
AR222207A1 (es) 1981-04-30
CA1144071A (fr) 1983-04-05
ATE20182T1 (de) 1986-06-15
FI790350A (fi) 1980-08-03
EP0014514A2 (fr) 1980-08-20
PT70719A (en) 1980-02-01
GR65623B (en) 1980-10-15
DK28480A (da) 1980-08-03
ES8102702A1 (es) 1981-02-16
ES488168A0 (es) 1981-02-16
US4351825A (en) 1982-09-28
EP0014514B1 (fr) 1986-06-04
DE3071625D1 (en) 1986-07-10
JPS55129222A (en) 1980-10-06
IE51741B1 (en) 1987-03-18
FI63335B (fi) 1983-02-28
EP0014514A3 (en) 1981-06-10
IE800202L (en) 1980-08-02
NO149490B (no) 1984-01-23

Similar Documents

Publication Publication Date Title
ZA80553B (en) Process for the preparation of tablets with retarded liberation of the active agent,in which tablets the rate of liberation of the active agent is predetermined
PT72278A (en) Process for the preparation of 2-acylaminomethyl-1,4-benzodiazepines and salts thereof
HU175439B (hu) Insekticidnye kompozicii soderzhahhie proizvodnye n-skobka-3-triflorometil-4-galogeno-fenil-skobka zakryta-n-zapjataja vverkh-benzoil-mocheviny i sposob poluchenija aktivnogo agenta
GB2061866B (en) Process for preparing pharmaceutically active compound-containing microcapsules
IL52749A0 (en) Process for the preparation of m-phenoxybenzaldehyde
GB1523529A (en) Process for the preparation of tetrazole - 5 - carboxamides
HK30381A (en) Process for the preparation of gamma-pyrones
DE3063952D1 (en) Process for the preparation of riboflavin
DE3060382D1 (en) Process for the preparation of aqueous solutions of alkali-organosiliconates
GB1534213A (en) Process for the preparation of basically-substituted phenyl-acetonitriles
HUT37036A (en) Process for preparing pharmaceutical compositions with retarded release of the active substance
DE3063909D1 (en) Organomagnesium alkoxides, process for their preparation and stable solutions of these compounds
ZA813935B (en) Indene derivatives,processes for their preparation,and their use as medicaments
GB2007095B (en) Process for the manufacture of biologiacally active granules
HU174981B (hu) Sposob poluchenija n-skobka-1-allil-2-pirrolidilmetil-skobka zakryta-2,3-dimetoksi-5-sul&#39;famoil-benzamida i farmacevticheskikh kompozicijj soderzhahhikh ikh aktivnymi agentami
PT72020B (en) Process for the preparation of active dried microorganisms
CH609341A5 (en) Process for the preparation of 5-methylisoxazole- 4-carboxanilides
GB1552402A (en) Process for the preparation of 3-deoxyanthocyanidins
PT67402B (en) Process for the preparation of pharmaceutical compositionscomprising stable solutions of oxytetracycline
PT67431B (en) Process for preparation of 1-amino-lower-alkyl-3,4-diphenyl-1h-pyrazoles
GB1549547A (en) Process for the preparation of 4-phenoxy-phenols
ZA773011B (en) Process for the preparation of 2-aryliminothiazoline solutions
GB1519931A (en) Process for the preparation of ethyl aminocyanoacetate
PT66862B (en) Process for the preparation of cyanoprostaglandins
DE2861651D1 (en) Spirobenzofuranone compounds, processes for their preparation and their use as medicines